|
2007P-0194:ANDA Suitability for Acetaminophen, Butalbital, Caffeine and Hydrocodone Bitartrate Capsules, 650 mg / 50 mg /40 mg / 5 mg
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed Date
|
| Submitter Code
|
| Submitter
|
| FR Date
|
| FR Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 05/11/2007
|
| 05/11/2007
|
| Private
Industry
|
| Lachman Consultant
Services, Inc.
|
|
|
|
|
|
|
| Table of Contents
|
|
|
|
|
| Signature:
|
| Robert W. Pollock
|
|
|
|
|
| ACK1
|
| 05/11/2007
|
| 05/11/2007
|
| Federal
Government
|
| FDA / DDM to Lachman
Consultant Services, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Gloria Ortega
|
|
|
| |
|
|
|
| EC1
|
| 06/01/2007
|
| 05/30/2007
|
| Individual
Consumer
|
| Mrs. Tammy
Evans
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Top | Up
Page last updated:
June 19, 2007
|
